Should Warren Buffet worry about Ram Shriram?
Ram Shriram of Sherpalo Ventures, an early investor in Google, is free to become a billionaire anytime – ie, anytime GOOG trades above $190. As of last Tuesday (November 16,…
Heralding “global-from-day-one” start-ups
As I was going through the program agenda of Ernst & Young’s Israel-India-China Global Hotbed Cross-Border Company Showcase event (at the San Mateo Marriott on November 4, 2004), I was…
Indian gaming industry to grow 5-fold by 2006-07: KPMG survey
Fuelled by booming demand for mobile games and local content, the Indian gaming content industry is set to grow five fold to touch $100 million by 2006-07, according to a…
“VCs are a hindrance for experienced entrepreneurs”: Kintera CEO
While venture capital serves a valuable role in providing capital and partnership to young entrepreneurs, “if you have a seasoned management team and a track record, VCs are more of…
Entrepreneurs preferring to be stealth: KPCB partners
It is tough to do venture capital research in the US these days. Start-ups that receive VC funding are no longer keen to publicize their fund raising. So much so…
Ram Shriram’s “Book of Mistakes”
Ram Shriram, founder of Sherpalo Ventures, and one of the first investors in Google, helped Google’s co-founders “in the Menlo Park garage by consulting his ‘Ram’s Book of Mistakes’, reports…
Profile of Open-Silicon’s founder
siliconindia magazine has published a profile of Dr. Naveed Sherwani, Co-Founder, President & CEO of ASIC design and development firm Open-Silicon.
“Indian founders in Silicon Valley do not last long as CEOs post VC funding”: report
According to a report in siliconindia magazine, “Indians who have founded technology companies – in hardware, software, or innovative biotech – are in serious trouble, once they land some venture…
Bad VC vs Good VC
Extracts from a great post by William Luciw, Managing Director, Viewpoint West Partners LLC, in the AlwaysOn-Network blogzinw: (-) BAD VC: Refers to “Winning DNA” and uses this nebulous criteria…
India emerges as new drug trial hot spot
Extracts from an Always-On Network posting: India’s small but fast growing clinical trials industry has the potential to significantly lower drug development costs for U.S. and global companies. Drug trials…